Paul Y. Song - 05 May 2025 Form 4 Insider Report for NKGen Biotech, Inc. (NKGN)

Role
Chief Executive Officer
Signature
/s/ Paul Y. Song
Issuer symbol
NKGN
Transactions as of
05 May 2025
Net transactions value
+$7,950,000
Form type
4
Filing time
07 May 2025, 16:05:15 UTC
Previous filing
10 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Song Paul Y. Chief Executive Officer NKGEN BIOTECH, INC., 3001 DAIMLER STREET, SANTA ANA /s/ Paul Y. Song 07 May 2025 0001991119

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKGN Common Stock Purchase $2,650,000 +20,849,725 +12184% $0.1271 21,020,846 05 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKGN Warrant Purchase $5,300,000 +41,699,449 $0.1271 41,699,449 05 May 2025 Common Stock 41,699,449 $0.1271 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 5, 2025, the Reporting Person purchased 20,849,725 shares of common stock of the Company, $0.0001 par value per share ("Common Stock") pursuant to that certain Securities Purchase Agreement (the "SPA").
F2 On May 5, 2025, the Reporting Person purchased 41,699,449 warrants to purchase shares of Common Stock in connection with the SPA and pursuant to that certain Common Stock Purchase Warrant.